Nuffield Department of Women's & Reproductive Health, University of Oxford, Women's Centre, John Radcliffe Hospital, Oxford, OX3 9DU, United Kingdom.
Nanomedicine (Lond). 2024;19(14):1231-1251. doi: 10.2217/nnm-2023-0346. Epub 2024 May 21.
Nanoparticles and nanotechnology may present opportunities to revolutionize the prevention, treatment and diagnosis of a range of reproductive health conditions in women. These technologies are also used to improve outcomes of assisted reproductive technology. We highlight a range of these potential clinical uses of nanoparticles for polycystic ovary syndrome, endometriosis, uterine fibroids and sexually transmitted infections, considering and studies along with clinical trials. In addition, we discuss applications of nanoparticles in assisted reproductive technology, including sperm loading, gamete and embryo preservation and preventing preterm birth. Finally, we present some of the concerns associated with the medical use of nanoparticles, identifying routes for further exploration before nanoparticles can be applied to women's reproductive health in the clinic.
纳米颗粒和纳米技术可能为一系列女性生殖健康状况的预防、治疗和诊断带来革命性变化。这些技术也被用于改善辅助生殖技术的治疗效果。我们重点介绍了纳米颗粒在多囊卵巢综合征、子宫内膜异位症、子宫肌瘤和性传播感染等方面的一系列潜在临床应用,同时考虑了 和 研究以及临床试验。此外,我们还讨论了纳米颗粒在辅助生殖技术中的应用,包括精子加载、配子和胚胎保存以及预防早产。最后,我们提出了一些与纳米颗粒医学应用相关的问题,并确定了在纳米颗粒应用于临床女性生殖健康之前需要进一步探索的途径。